期刊文献+

人血浆中盐酸马尼地平的LC-MS法测定及药动学 被引量:4

Determination of Manidipine Hydrochloride in Human Plasma by LC-MS and Its Pharmacokinetics
下载PDF
导出
摘要 建立了LC-MS法测定人血浆中盐酸马尼地平的浓度,并研究了12名健康志愿者单剂量和多剂量口服盐酸马尼地平后的药物动力学。以尼莫地平为内标,采用Venusil XBP C8色谱柱,5mmol/L乙酸铵溶液(含0.5%乙酸)-甲醇-乙腈(15∶40∶45)为流动相,流速0.6ml/min,血浆样品经乙酸乙酯萃取。AP-ESI离子源,正离子模式,采集离子马尼地平为611.4(M+1)和尼莫地平为441.1(M+Na)。盐酸马尼地平在0.25~50ng/ml浓度范围内线性关系良好,方法回收率和提取回收率分别大于99%和49%,日内、日间RSD均小于8%。 A LC-MS method was established for the determination of manidipine hydrochloride in human plasma. Pharmacokinetics after single dose and multi dose oral administration of manidipine hydrochloride in 12 healthy volunteers were discussed. The analytes were extracted by ethyl acetate and nimodipine was used as internal standard. A Venusil XBP C8 column was used, with mobile phase of 5 mmol/L ammonium acetate solution (containing 0.5% acetic acid)-methanol-acetonitrile (15 : 40 : 45). The flow rate was 0.6ml/min. Atmospheric pressure electronic spray ionization (AP-ESI)was used, and it was operated in the positive ion mode. Selected ion monitoring ions were 611.4 (M+ 1) for manidipine and 441.1 (M+Na) for nimodipine, respectively. The calibration curve of manidipine hydrochloride was linear in the concentration range of 0.25 - 50ng/ml. The recovery and extraction recovery were more than 99 % and 49 %, respectively. The RSDs of intra- and inter-day were less than 8 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2007年第9期653-655,共3页 Chinese Journal of Pharmaceuticals
关键词 盐酸马尼地平 液相色谱-质谱 药物动力学 测定 manidipine LC-MS pharmacokinetics determination
  • 相关文献

参考文献5

  • 1Nayler WG,Panagiotopoulos S.The antiatherosclerotic effect of the calcium antagonists and their implications in hypertension[J].Am Heart J,1993,125 (2 pt 2):626-629.
  • 2Saruta T,Suzuki H.Efficacy of manidipine in the treatment of hypertension with renal impairment:a multicenter trial[J].Am Heart J,1993,125 (2 pt 2):630-634.
  • 3Fogari R,Zoppi A,Mugellini A,et al.Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives[J].Cardiovasc Drugs Ther,1999,13 (3):243-248
  • 4Cheer SM,McClellan K.Manidipine:a review of its use in hypertension[J].Drugs,2001,61 (12):1777-1799.
  • 5黄震华.新型钙通道拮抗剂马尼地平[J].中国新药与临床杂志,2003,22(4):241-244. 被引量:18

二级参考文献18

  • 1[1]DHEIN S, SALAMEH A, BERKELS R, et al. Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide[J]. Drugs, 1999, 58(3):397-404.
  • 2[2]Anon. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure[J]. Arch Intern Med, 1997, 157(21):2413-2446.
  • 3[3]LUSCHER TF, COSENTINO F. The classification of calcium antagonists and their selection in the treatment of hypertension: a reappraisal[J]. Drugs, 1998, 55(4):509-517.
  • 4[4]OKABE K, TERADA K, KITAMURA K, et al. Selective and long-lasting inhibitory action of the dihydropyridine derivative, CV-4093, on calcium currents in smooth muscle cells of the rabbit pulmonary artery[J]. J Pharmacol Exp Ther, 1987, 243(2):703-710.
  • 5[5]CHEER SM, MCCLELLAN K. Manidipine: a review of its use in hypertension[J]. Drugs, 2001, 61(12):1777-1799.
  • 6[6]PFAFFENDORF M, MATHY MJ, van ZWIETEN PA. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries[J]. Am Heart J, 1993, 125(2 Pt 2): 571-577.
  • 7[7]FOGARI R, ZOPPI A, MUGELLINI A, et al. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives[J]. Cardiovasc Drugs Ther, 1999, 13(3):243-248.
  • 8[8]MANCIA G, OMBONI S, AGABITI-ROSEI E, et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients[J]. J Cardiovas Pharmacol, 2000, 35(6):926-931.
  • 9[9]HASE MI, HASE O, IGAWA S, et al. Reduction of left ventricular mass by manidipine hydrochloride[J]. Am J Hypertens, 1998, 11(4 Pt 2):81A.
  • 10[10]TAKABATAKE T, USHIOGI Y, ISE T, et al. Effect of calcium antagonist, manidipine hydrochloride, on renal hemodynamics and tubuloglomerular feedback in spontaneously hypertensive rats[J]. Am Heart J, 1993, 125(2 Pt 2):578-581.

共引文献17

同被引文献26

  • 1陈宁,张琪,杜宇,陈国广,朱玲玲.黄芪甲苷在大鼠体内的药代动力学和组织分布研究[J].生物加工过程,2006,4(3):67-72. 被引量:13
  • 2文爱东,贾艳艳,罗晓星,毕琳琳,周敏,黄荻,丁莉坤.液相色谱-质谱法测定人血浆中复方赖诺普利及其人体药动学研究[J].中国新药与临床杂志,2006,25(12):897-901. 被引量:7
  • 3钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 4Mugellini A, Dobovisek J, Planinc D, et al. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hy- pertension: results of a randomized trial[J]. Clin Ther, 2004,26(9):1 419.
  • 5Roberto F. Rationale for use of the fixed combination of delapril and manidipine in the treatment of hypertension in patients with diabetes mellitus[J]. Clinical Therapeu- tics, 2007,29(2) : S54.
  • 6Otero ML, Claros NM, Study Investigators Group. Mani- dipine versus enalapril monotherapy in patients with hy- pertension and type 2 diabetes mellitus: A multicenter, randomized, double-blind, 24-week study[J].Clin Ther, 2005,27(2) : 166.
  • 7Kang W, Lee DJ, Liu KH, et al. Analysis of benidipine enantiomers in human plasma by liquid chromatography- mass spectrometry using a macrocyclic antibiotic (Vanco- myein) chiral stationary phase column[J]. Chromatogr B Analyt Technol BiomedLife Sci, 2005,814( 1 ) : 75.
  • 8FOGARI R, MUGELLINI A, ZOPPI A, et al. Effect of manidipine and lisinopril on albuminuria and ventricu- lar mass in diabetic hypertensive patients with mi- croalbuminuria I J ~. American Journal of Hyperten- sion,2001,14(4) :A219.
  • 9HUANG J,XU Y,LIU F, et al. Development of a liq- uid chromatography/tandem mass spectrometry assay for the quantification of lisinopril in human plasma [ J ]. Rapid Communications in Mass Spectrometry, 2006,20(2) :248 -252.
  • 10TODESCHINI V, SANGOI MDA S, VOLPATO N M. Delapril and manidipine measurements by liquid chromatography-tandem mass spectrometry in a phar- macetical for mulation [ J ]. European Journal of Mass Spectrometry ( Chichester, England ) , 2011, 17 ( 3 ) : 287 - 296.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部